Medical Microbiology for the New Curriculum: A Case-Based Approach

Medical Microbiology for the New Curriculum: A Case-Based Approach

Volumn , Issue , 2007, Pages 1-289

  Carey, Roberta B ^a,b   Schuster, Mindy G ^c   McGowan, Karin L ^c,d  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79960096045     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470174296     Document Type: Book

References (106)

1. Keller,M. And P. Keller, Making Harvard Modern: The Rise of America's University, Oxford University Press, 2001.
2. Bisno, A. L.,M.A.Gerber, J. M. Gwaltney, E. L. Kaplan, And R. H. Schwartz, Practice guidelines for the diagnosis and management of groupAstreptococcal pharyngitis, Clin. Infect. Dis. 35: 113-125 (2002).
3. Cunningham, M. W., Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13: 470-511 (2000).
4. Red Book, Report of the Committee on Infectious Diseases of the American Academy of Pediatrics, 27th ed., 2006, pp. 610-620.
5. Stevens, D. L., Streptococcal toxic shock syndrome: Spectrum of disease, pathogenesis, and new concepts in treatment, Emerg. Infect. Dis. 1: 69-78 (1995).
6. Hooton, T. M., D. Scholes, J. P. Hughes, et al., A prospective study of risk factors for symptomatic urinary tract infection in young women, New Engl. J. Med. 335: 468-474 (1996).
7. Kunin, C. M., Urinary Tract Infections, 5th ed., Williams &Wilkins, Baltimore, 1997.
8. Nickel, J. C., Management of urinary tract infections: Historical perspective and current strategies: Part 2-Modern management, J. Urol. 173: 27-32 (2005).
9. Nicolle, L. E., S. Bradley, R. Colgan, J. C. Rice, A. Schaeffer, And T. M. Hooton, Infectious Diseases Society ofAmerica guidelines for the diagnosis and treatment of asymptomatic bacteruria in adults, Clin. Infect. Dis. 40: 643-654 (2005).
10. Dennehy, P. H., Acute diarrheal disease in children: Epidemiology, prevention, and treatment, Infect. Dis. Clin. N. Am. 19: 585-602 (2005).
11. Dupont, H. L., What's new in enteric infectious diseases at home and abroad, Curr. Opin. Infect. Dis. 18: 407-412 (2005).
12. Guerrant, R. L., T. Van Gilder, T. S. Steiner Et Al., Practice guidelines for the management of infectious diarrhea, Clin. Infect. Dis. 32: 331-350 (2001).
13. Welinder-Olsson, C. And B. Kaijser, Enterohemorrhagic Escherichia coli (EHEC), Scand. J. Infect. Dis. 37: 405-416 (2005).
14. Ayeh-Kuni, P. F., M. Phil, And W.A. Petri, Diagnosis and management of amebiasis, Infect. Med. 19: 375-382 (2002).
15. Diemert, D. J., Prevention and self-treatment of traveler's diarrhea, Clin. Microbiol. Rev. 19: 583-594 (2006).
16. Dupont, H. L., What's new in enteric infectious diseases at home and abroad, Curr. Opin. Infect. Dis. 18: 407-412 (2005).
17. Espinosa-Cantellano, M. And A. Martinezpalomo, Pathogenesis of intestinal amebiasis: Frommolecules to disease, Clin.Microbiol. Rev. 13: 318-331 (2000).
18. Okhuysen, P. C., Current concepts in traveler's diarrhea: Epidemiology, antimicrobial resistance and treatment, Curr. Opin. Infect. Dis. 18: 522-526 (2005).
19. Borgers, M., H. Degreef, And G. Cauwenbergh, Fungal infections of the skin: Infection process and anti-mycotic therapy, Curr. Drug Targets 6: 849-862 (2005).
20. Hainer, B. L., Dermatophyte infections, Am. Fam. Physician 67: 101-108 (2003).
21. Weinstein, A. And B. Berman, Topical treatment of common superficial tinea infections, Am. Fam. Physician 65: 2095-2102 (2002).
22. CDC, CDC anthrax investigation updates and new information, MMWR 50:1-4 (2001).
23. CDC, Inhalation anthrax associated with dried animal hides-Pennsylvania and New York City, MMWR 55:280-282 (2006).
24. Daya, M. And Y. Nakamura, Pulmonary disease from biological agents: Anthrax, plague, Q fever, and tularemia, Crit. Care Clin. 21: 747-763 (2005).
25. Holty, J. E., D. M. Bravata, H. Liu, R. A. Olshen, K.M.Mcdonald, And D. K.Owens, Systematic review: A century of inhalational anthrax cases from 1900 to 2005, Ann. Intern. Med. 144:270-280 (2006).
26. JAMA Consensus Statement, Anthrax as a biological weapon: Medical and public health management, JAMA 281:1735-1745 (1999).
27. Barberan, J., Management of infections of osteoarticular prosthesis, Clin. Microbiol. Infect. 12(Suppl. 3):93-101 (2006).
28. Cunha, B. A., Methicillin-resistant Staphylococcus aureus: Clinical manifestations and antimicrobial therapy, Clin. Microbiol. Infect. 11(Suppl. 4):33-42 (2005).
29. Garner, J. S., Hospital Infection Control Practice Advisory Committee (HICPAC) Guidelines for isolation precautions in hospitals, Infect. Control Hosp. Epi. 17:53-80 (1996).
30. www.cdc.gov/ncidod/hip/isolat.
31. Gordon, S. M., Antibiotic prophylaxis against postoperative wound infections, Clev. Clin. J. Med. 73(Suppl. 1):S42-S45 (2006).
32. www.cdc.gov/ncidod/hip/ARESIST/mrsafaq.htm.
33. Zimmerli, W., A. Trampuz, And P. E. Ochsner, Prosthetic-joint infections, N. Engl. J. Med. 351:1645-1654 (2004).
34. Calhoun, J. H. And M. M. Manring, Adult osteomyelitis, Infect.Dis.Clin.N.Am. 19: 765-786 (2005).
35. Kaplan, S. L., Osteomyelitis in children, Infect. Dis. Clin. N. Am. 19: 787-797 (2005).
36. Salyers, A. A. And D. D. Whitt, Bacterial Pathogenesis: A Molecular Approach, 2nd ed., ASM Press, Washington, DC, 2002, pp. 247-262.
37. Trautmann, M., P.M. Lepper, And M. Haller, Ecology of Pseudomonas aeruginosa in the intensive care unit and the evolving role of water outlets as a reservoir for the organism, Am. J. Infect. Control 33: S41-S49 (2005).
38. CDC, Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections-2002, MMWR 51 (RR-15):1-38 (2002).
39. CDC, Sexually transmitted diseases treatment guidelines: 2006, MMWR 55 (RR-11):1-94 (2006).
40. CDC. Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR 56:332-336.
41. Edwards, J. L. And M. A. Apicella, The molecular mechanisms used by Neisseria gonorrhoeae to initiate infection differ between men and women, Clin.Microbiol. Rev. 17:965-981 (2004).
42. Olshen, E.Andl. A. Shrier,Diagnostics tests for chlamydial and gonorrheal infections, Semin. Pediatr. Infect. Dis. 16:192-198 (2005).
43. File, T. M., Clinical implications and treatment of multiresistant Streptococcus pneumoniae pneumonia, Clin. Microbiol. Infect. 12 (Suppl. 3):31-41 (2006).
44. Mandell, L. A., Antimicrobial resistance and treatment of community-acquired pneumonia, Clin. Chest Med. 26:57-64 (2005).
45. Mandell L. A., R. G. Wunderink, A. Anzueto, J. G. Bartlett, G. D. Campbell, N. C. Dean, S. F. Dowell, T. M. File, Jr., D. M. Musher, M. S. Niederman, A. Torres, And C. G. Whitney, Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults, Clin. Infect. Dis. 44 (Suppl 2):S27-S72 (2007).
46. Mcintosh,K., Community-acquired pneumonia in children, N. Engl. J. Med. 346:429-37 (2002).
47. Ortqvist, A., J.Hedlund,Andm.Kalin, Streptococcus pneumoniae: Epidemiology, risk factors, and clinical features, Semin. Resp. Crit. Care Med. 26:563-574 (2005).
48. CDC, Prevention and control of influenza: Recommendations of the advisory committee on immunization practices (ACIP), MMWR 55(RR-10):1-42 (2006).
49. Ebell, M. H., Diagnosing and treating patients with suspected influenza, Am. Fam. Physician 72:1789-1792 (2005).
50. Falsey, A. R. And E. E. Walsh, Viral pneumonia in older adults, Clin. Infect. Dis. 42:518-524 (2006).
51. Ruiz,M., S. Ewig,M. A.Marcos, J. A.Martinez, F. Arancibia, J. Mensa, And A. Torres, Etiology of community-acquired pneumonia: Impact of age, co-morbidity, and severity, Am. J. Crit. Care Med. 160:397-405 (1999).
52. www.cdc.gov/flu.
53. Bonnet, D., A. A. Schmaltz, And T. F. Feltes, Infection by the respiratory syncytial virus in infants and young children at high risk, Cardiol. Young. 15:256-265 (2005).
54. CDC, Pertussis-United States, 2001-2003, MMWR 54:1283-1286 (2005).
55. Chidgey, S. M. And K. J. Broadley, Respiratory syncytial virus infections: Characteristics and treatment, J. Pharm. Pharmacol. 57:1371-1381 (2005).
56. Falsey, A. R., P. A. Hennessey, M. A. Formica, C. Cox, And E. E. Walsh, Respiratory syncytial virus infection in elderly and high risk adults, N. Engl. J. Med. 352:1749-1759 (2005).
57. Leidy, N. K., M. K. Margolis, J. P. Marcin, J. A. Flynn, L. R. Frankel, S. Johnson, D. Langkamp, And E. A. Simoes, The impact of severe respiratory syncytial virus on the child, caregiver, and family during hospitalization and recovery. Pediatrics, 115:1536-1546 (2005).
58. Campbell, I. A. And O. Bah-Sow, Pulmonary tuberculosis: Diagnosis and treatment, Br. Med. J. 332:1194-1197 (2006).
59. CDC, Trends in tuberculosis-United States, 1998-2003, MMWR 53:209-214 (2004).
60. CDC, Controlling tuberculosis in the United States, MMWR 54(RR-12):1-81 (2005).
61. CDC, Guidelines for preventing the transmission of Mycobacterium tuberculosis in healthcare settings, MMWR 54(RR-17):1-141 (2005).
62. Kato-Maeda, M. And P. M. Small, User's guide to tuberculosis resources on the internet, Clin. Infect. Dis. 32:1580-1588 (2001).
63. Myers, J. P., New recommendations for the treatment of tuberculosis, Curr. Opin. Infect. Dis. 18:133-140 (2005).
64. Panackal, A. A., R. A. Hajjeh, M. S. Cetron, And D. W. Warnock, Fungal infections among returning travelers, Clin. Infect. Dis. 35:1088-1095 (2002).
65. Wheat, L. J. Histoplasmosis: A review for clinicians from non-endemic areas, Mycoses 49:274-282 (2006).
66. Wheat, L. J., G. Sarosi, D. Mckinsey Et Al., Practice guidelines for the management of patients with histoplasmosis, Clin. Infect. Dis. 30:688-695 (2000).
67. Larocco, M. T. And S. J. Burgert, Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation, Clin.Microbiol. Rev. 10:277-297 (1997).
68. Latge, J. P. Aspergillus fumigatus and aspergillosis, Clin. Microbiol. Rev. 12:310-350 (1999).
69. Maertens, J., J. V. Eldere, J. Verhaegen et al., Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients, J. Infect. Dis. 186:1297-1306 (2002).
70. Stevens, D. A., V. L. Kan, M. A. Judson Et Al., Practice guidelines for diseases caused by Aspergillus, Clin. Infect. Dis. 30: 696-709 (2000).
71. CDC, Prevention and control of meningococcal disease, MMWR 49(RR-07): 1-10 (2000).
72. Chavez-Bueno, S. And G. H. Mccracken, Jr., Bacterial meningitis in children, Pediatr. Clin. N. Am. 52:795-810 (2005).
73. Sinner, S. W. And A. R. Tunkel, Antimicrobial agents in the treatment of bacterial meningitis, Infect. Dis. Clin. N. Am. 18:581-602 (2004).
74. Van De Beek, D., J. De Gans, A. R. Tunkel, And E. F.Wijdicks, Community-acquired bacterial meningitis in adults, N. Engl. J.Med. 354: 44-53 (2006).
75. Van Deuren, M, P. Brandtzaeg, And J.W.M. Van Der Neer, Update on meningococcal disease with emphasis on pathogenesis and clinical management, Clin. Microbiol. Rev. 13: 144-166 (2000).
76. CDC, Enterovirus surveillance-United States, 1970-2005, MMWR 55(SS-08):1-20 (2006).
77. Dubos, F., B. Lamotte, F. Bibi-Triki, F. Moulin, J. Raymond, D. Gendrel, G. Breart, Andm. Chalumeau, Clinical decision rules to distinguish between bacterial and aseptic meningitis, Arch. Dis. Child. 91:647-50 (2006).
78. Kupila, L., T. Vuorinen, R. Vainionpaa, V. Hukkanen, R. J. Marttila, And P. Kotilainen, Etiology of aseptic meningitis and encephalitis in an adult population, Neurol. 66:75-80 (2006).
79. Sawyer, M. H, Enterovirus infections: Diagnosis and treatment, Pediatr. Infect. Dis. J. 18:1033-1039 (1999).
80. CDC, Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC, MMWR 51(RR-11):1-25 (2002).
81. Kimberlin, D. W. Neonatal herpes simplex infection, Clin. Microbiol. Rev. 17:1-13 (2004).
82. Vergnano, S., M. Sharland, P. Kazembe, C. Mwansambo, And P. T. Heath, Neonatal sepsis: An international perspective, Arch. Dis. Child. Fetal Neonat. Ed. 90:F220-F224 (2005).
83. Volante, E., S. Moretti, F. Pisani, And G. Bevilacqua. Early diagnosis of bacterial infection in the neonate, J. Matern. Fetal Neonat. Med. 16(Suppl. 2): 13-16 (2004).
84. Bicanic, T. And T.S. Harrison, Cryptococcal meningitis, Br. Med. Bull. 72:99-118 (2005).
85. Cohen, B. A., Chronic meningitis, Curr. Neurol. Neurosci. Rep. 5:429-439 (2005).
86. Pappas, P. G., Therapy of cryptococcalmeningitis in non-HIV-infected patients, Curr. Infect. Dis. Rep. 3: 365-370 (2001).
87. Saag, M. S., J. R.Graybill, R. A. Larsen, Et Al., Practice guidelines for the management of cryptococcal disease, Clin. Infect. Dis. 30:710-718 (2000).
88. Duerden, B. I., Virulence factors in anaerobes, Clin. Infect. Dis. 18(Suppl 4):S245-S320 (1994).
89. Hatheway, C. L., Toxigenic clostridia, Clin. Microbiol. Rev. 3:66-98 (1990).
90. Stevens, D. L. et al., Practice guidelines for the diagnosis and management of skin and soft tissue infections, Clin. Infect. Dis. 41:1373-1406 (2005).
91. American College of Cardiology/American Heart Association 2006 guidelines for the management of patients with valvular heart disease, Circulation 114: e84-e231 (2006).
92. Baddour, L. M., W. R. Wilson, A. S. Bayer Et Al., Infective endocarditis: Diagnosis, antimicrobial therapy, and management of complications, Circulation 111: 3167-3184 (2005).
93. Bashore, T. M., C. Cabell, And V. Fowler, Jr., Update on infective endocarditis, Curr. Probl. Cardiol. 31: 274-352 (2006).
94. Brouqui, P. And D. Raoult, Endocarditis due to rare and fastidious bacteria, Clin.Microbiol. Rev. 14: 177-207 (2001).
95. Sexton, D. J. And D. Spelman, Current best practices and guidelines. Assessment and management of complications in infective endocarditis, Infect. Dis. Clin. N. Am. 2: 507-521 (2002).
96. Quagliarello, V., Infective endocarditis: Global, regional, and future perspectives, JAMA 293: 3061-3062 (2005).
97. CDC, A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States, MMWR 54(RR-16):1-39 (2005).
98. CDC, Hepatitis Fact Sheets, www.cdc.gov/hepatitis.
99. CDC, Hepatitis Frequently Asked Questions, www.cdc.gov/ncidod/diseases/hepatitis/.
100. Wong, S. N. And A. S. Lok, Treatment of hepatitis B:Who, when, and how? Arch. Intern.Med. 166:9-12 (2006).
101. CDC Treatment Guidelines, www.cdc.gov/malaria/pdf/treatmenttable.pdf.
102. CDC, Yellow Book. Health Information for International Travel, 2005-2006.
103. Moody, A., Rapid diagnostic tests for malaria parasites, Clin. Microbiol. Rev. 15:66-78 (2002).
104. CDC, Revised recommendations for HIV testing of adults, adolescents, and pregnant women in healthcare settings ,MMWR 55(RR-14):1-17 (2006).
105. CDC, Epidemiology of HIV/AIDS-U.S. 1981-2005, MMWR 55:589-592 (2006).
106. Saag, M. S., M. Holodniy, D. R. Kuritzkes, Et Al., HIV viral loadmarkers in clinical practice: Recommendations of an International AIDS Society--USA Expert Panel, Nature Med. 2:625-629 (1996).